Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Mark Schickendantz, MD, is the Director of Cleveland Clinic Sports Health.
He is also the Head Team Physician and Director of Orthopedic Services for the Cleveland Indians Professional Baseball Club, Associate Professor of Surgery with the Cleveland Clinic College of Medicine and Program Director and Clinical Instructor of Orthopedic Surgery for the Cleveland Clinic Sports Health.
His specialty interests include sports medicine and arthroscopic surgery of the shoulder and elbow. He sees patients who are 15 years and older.
He is board-certified by the American Board of Orthopedic Surgery.
Dr. Schickendantz earned his medical degree from Saint Louis University School of Medicine in St. Louis, Mo. He completed an internship in general surgery and residency in orthopedic surgery at Cleveland Clinic in Cleveland, Ohio. He also held a fellowship in shoulder surgery and sports medicine at the Steadman Hawkins Clinic in Vail, Colo.
He is a member of a number of professional and medical societies, including the American Board of Orthopedic Surgery, a Fellow with the American Academy of Orthopedic Surgeons, and the Major League Baseball Team Physicians Association, among many others. He has published a number of peer-reviewed articles, has written book chapters and has presented at various research meetings.
Sports medicine, arthroscopic shoulder and elbow surgery.
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland
Clinic's procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. The Cleveland Clinic requires its doctors to approve the public disclosures of their scientific collaborations with industry. As of 8/31/2014 the review process regarding Dr. Schickendantz's disclosure had not been completed. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.